George Gauthier
Corporate Officer/Principal at IGM BIOSCIENCES, INC.
Net worth: 303 261 $ as of 30/04/2024
Profile
George A.
Gauthier is currently the Chief Commercial Officer at IGM Biosciences, Inc. Previously, he worked as the Vice President-Global Product Strategy at Genentech, Inc. He received his undergraduate degree from Michigan State University and his MBA from Kellogg School of Management.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IGM BIOSCIENCES, INC.
0.12% | 29/11/2023 | 39,642 ( 0.12% ) | 303 261 $ | 30/04/2024 |
George Gauthier active positions
| Companies | Position | Start |
|---|---|---|
| IGM BIOSCIENCES, INC. | Corporate Officer/Principal | 12/04/2021 |
Former positions of George Gauthier
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/04/2021 |
Training of George Gauthier
| Michigan State University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| IGM BIOSCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- George Gauthier
